References
- Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-1442. https://doi.org/10.1016/S0140-6736(96)07495-8
- Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F. Depression: cost-of-illness studies in the international literature, a review. J Ment Health Policy Econ 2000;3:3-10. https://doi.org/10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H
- Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 2015;76:155-162. https://doi.org/10.4088/JCP.14m09298
- Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 2007;16:560-570. https://doi.org/10.1002/pds.1367
- Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;109:55-64.
- Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:629-640. https://doi.org/10.1001/archpsyc.62.6.629
- Henriksson S, Asplund R, Boethius G, Hallstrom T, Isacsson G. Infrequent use of antidepressants in depressed individuals (an interview and prescription database study in a defined Swedish population 2001-2002). Eur Psychiatry 2006;21:355-360. https://doi.org/10.1016/j.eurpsy.2006.04.003
- Goldberg DP, Huxley P. Common Mental Disorders: A Bio-Social Model. London: Routledge;1992.
- Sireling LI, Freeling P, Paykel ES, Rao BM. Depression in general practice: clinical features and comparison with out-patients. Br J Psychiatry 1985;147:119-126. https://doi.org/10.1192/bjp.147.2.119
- Sireling LI, Paykel ES, Freeling P, Rao BM, Patel SP. Depression in general practice: case thresholds and diagnosis. Br J Psychiatry 1985;147:113-119. https://doi.org/10.1192/bjp.147.2.113
- Simon GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry 2001;58:395-401. https://doi.org/10.1001/archpsyc.58.4.395
- Vuorilehto MS, Melartin TK, Rytsala HJ, Isometsa ET. Do characteristics of patients with major depressive disorder differ between primary and psychiatric care? Psychol Med 2007;37:893-904. https://doi.org/10.1017/s0033291707000098
- McManus P, Mant A, Mitchell P, Britt H, Dudley J. Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry 2003;37:184-189. https://doi.org/10.1046/j.1440-1614.2003.01132.x
- Kerr MP. Antidepressant prescribing: a comparison between general practitioners and psychiatrists. Br J Gen Pract 1994;44:275-276.
- Sihvo S, Isometsa E, Kiviruusu O, Hamalainen J, Suvisaari J, Perala J, et al. Antidepressant utilisation patterns and determinants of shortterm and non-psychiatric use in the Finnish general adult population. J Affect Disord 2008;110:94-105. https://doi.org/10.1016/j.jad.2008.01.012
- Lawrence RE, Rasinski KA, Yoon JD, Meador KG, Koenig HG, Curlin FA. Primary care physicians' and psychiatrists' approaches to treating mild depression. Acta Psychiatr Scand 2012;126:385-392. https://doi.org/10.1111/j.1600-0447.2012.01887.x
- Kniesner TJ, Powers RH, Croghan TW. Provider type and depression treatment adequacy. Health Policy 2005;72:321-332. https://doi.org/10.1016/j.healthpol.2004.09.008
- Sturm R, Wells KB. How can care for depression become more costeffective? JAMA 1995;273:51-58. https://doi.org/10.1001/jama.1995.03520250067036
- Croghan TW, Melfi CA, Dobrez DG, Kniesner TJ. Effect of mental health specialty care on antidepressant length of therapy. Med Care 1999;37:AS20-AS23. https://doi.org/10.1097/00005650-199904001-00004
- Park K. Direction of health care and health insurance system reform to strengthen primary care: comparative analysis of Korea, Japan and Taiwan. J Korean Acad Fam Med 2003;24:328-345.
- American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Major Depressive Disorder. [serial online] 2010 Nov [cited 2019 Aug]. Available from URL: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf
- Desseilles M, Witte J, Chang TE, Iovieno N, Dording CM, Ashih H, et al. Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire. J Clin Psychiatry 2011;72:1152-1154. https://doi.org/10.4088/JCP.11ac07225
- Fife D, Feng Y, Wang MY, Chang CJ, Liu CY, Juang HT, et al. Epidemiology of pharmaceutically treated depression and treatment resistant depression in Taiwan. Psychiatry Res 2017;252:277-283. https://doi.org/10.1016/j.psychres.2017.03.006
- Davidson JR, Miller RD, Turnbull CD, Sullivan JL. Atypical depression. Arch Gen Psychiatry 1982;39:527-534. https://doi.org/10.1001/archpsyc.1982.04290050015005
- Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996;35:1427-1439. https://doi.org/10.1097/00004583-199611000-00011
- Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627. https://doi.org/10.1001/archpsyc.62.6.617
- Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry 2004;65:810-819. https://doi.org/10.4088/JCP.v65n0612
- Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333-340. https://doi.org/10.1001/jama.1997.03540280071036
- Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999;60:4-9.
- Weilburg JB, O'Leary KM, Meigs JB, Hennen J, Stafford RS. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 2003;54:1233-1239. https://doi.org/10.1176/appi.ps.54.9.1233
- Tarricone R. Metodologia di indagine e primi risultati sul costo sociale della depressione maggiore in Italia. Mecosan 1997;6:57-68.
- Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003;13:69-75. https://doi.org/10.1016/S0924-977X(03)00095-6
- Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997;43:27-39. https://doi.org/10.1016/S0165-0327(96)00095-X
- Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol 1994;8:48-52. https://doi.org/10.1177/026988119400800108
- Tai-Seale M, Croghan TW, Obenchain R. Determinants of antidepressant treatment compliance: implications for policy. Med Care Res Rev 2000;57:491-512. https://doi.org/10.1177/107755870005700405